Literature DB >> 11068369

[A study of patient's and doctor's delay in patients with pulmonary tuberculosis discovered by visiting doctors with symptoms in particular on doctor's delay].

Y Sasaki1, F Yamagishi, T Yagi, H Yamatani, F Kuroda, H Shoda.   

Abstract

Epidemiological trend of tuberculosis in Japan has reversed recently. The incidence of pulmonary tuberculosis (PTB) patients has increased again in Japan, and many outbreaks of PTB including nosocomial outbreaks in health-care facilities have been reported. The purpose of this study is to investigate patient's delay (interval between onset of the disease and first visit to a doctor) and doctor's delay (interval between first visit to a doctor and diagnosis as TB) in patients with PTB discovered by visiting doctors with symptoms, and especially, to investigate causes of doctor's delay in details. Of 236 PTB patients who were admitted to our hospital for treatment in 1997, 118 patients (85 males, 33 females) who were detected by their symptomatic visits were enrolled in to this study. 97 were initial treatment cases and the others were re-treatment cases. Among 34 initial treatment cases who were first seen at a general hospital and diagnosed as PTB by a close medical checkup after admission to our hospital, the 50 percentile of patient's delay was 17.0 days, and the 80 percentile was 36.4 days. The 50 percentile doctor's delay was 19.6 days, and the 80 percentile was 64.2 days. The average hospital stay was 16.2 days, the 50 percentile hospital stay was 7.8 days, and 80 percentile hospital stay was 23.5 days. On the sputum test for acid fast bacilli (AFB) performed on admission to our hospital, 26(76%) out of 34 cases were positive for tubercle bacilli, with 18 cases were positive for smear and 8 cases positive for culture. Therefore, risk of nosocomial infection was suspected. Doctor's delay had been attributed mainly to insufficient medical checkup. Among 25 initial treatment cases in whom doctor's delay as more than 4 weeks, 11 cases (44%) showed delay in chest X-ray examination and 8 cases (32%) ordered no sputum examination in spite of recognition of abnormal shadows on chest X-ray. On the sputum test for AFB on admission to our hospital, 22 (88%) out of 25 cases were positive for tubercle bacilli. Therefore, it is assumed that the delay in the adequate medical checkup was accountable for the doctor's delay. Shortening of the doctor's delay could be possible if hospitals perform the sputum examination for AFB and chest X-ray examinations properly for patients with respiratory symptoms.

Entities:  

Mesh:

Year:  2000        PMID: 11068369

Source DB:  PubMed          Journal:  Kekkaku        ISSN: 0022-9776


  5 in total

Review 1.  Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature.

Authors:  Chandrashekhar T Sreeramareddy; Kishore V Panduru; Joris Menten; J Van den Ende
Journal:  BMC Infect Dis       Date:  2009-06-11       Impact factor: 3.090

2.  Pulmonary tuberculosis in mumbai, India: factors responsible for patient and treatment delays.

Authors:  Ashutosh Tamhane; Girish Ambe; Sten H Vermund; Connie L Kohler; Alka Karande; Nalini Sathiakumar
Journal:  Int J Prev Med       Date:  2012-08

3.  [Pulmonary tuberculosis mortality risk factors].

Authors:  Hicham Janah; Hicham Souhi; Hatim Kouismi; Karima Mark; Rachida Zahraoui; Jouda Benamor; Mona Soualhi; Jamal Eddine Bourkadi
Journal:  Pan Afr Med J       Date:  2014-12-03

4.  Neurological Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA): The Roles of History and Physical Examinations in the Diagnosis of EGPA.

Authors:  Hiroshi Oiwa; Sho Mokuda; Tomoyasu Matsubara; Masamoto Funaki; Ikuko Takeda; Takemori Yamawaki; Kazuhiko Kumagai; Eiji Sugiyama
Journal:  Intern Med       Date:  2017-09-15       Impact factor: 1.271

Review 5.  A systematic review of delay in the diagnosis and treatment of tuberculosis.

Authors:  Dag Gundersen Storla; Solomon Yimer; Gunnar Aksel Bjune
Journal:  BMC Public Health       Date:  2008-01-14       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.